Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
May-2018 Volume 15 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2018 Volume 15 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma

  • Authors:
    • Xiaopeng Mao
    • Baimou Li
    • Ying Liang
    • Shuhua Li
    • Jianwen Zhou
    • Qiong He
    • Neng Jiang
    • Yangshan Chen
    • Yu Sun
    • Yongmei Cui
    • Wenting Jiang
    • Han Wang
    • Liantang Wang
    • Zunfu Ke
  • View Affiliations / Copyright

    Affiliations: Department of Pathology, The First Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Nephrology, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong 510010, P.R. China
  • Pages: 6533-6540
    |
    Published online on: March 1, 2018
       https://doi.org/10.3892/ol.2018.8137
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to investigate the significance of detecting cyclin dependent kinase inhibitor 2A (p16) gene aberrations in the diagnosis of urothelial carcinoma (UC) using fluorescence in situ hybridization (FISH). A total of 77 voided urine specimens from 65 patients with UC and 12 patients with benign urinary disease were recruited into the current study. Under a fluorescence microscope, cells with large and irregular nuclei were assessed for chromosomal aberrations. The positive rate of p16 amplification in UC samples was 32.3% (21/65), which was significantly higher than that in benign urinary disease samples (16.7%, 2/12; P<0.05). Heterozygous and homozygous loss of p16 was identified in 12 (18.5%) and 23 (35.4%) patients with UC, respectively; p16 expression in the remainder of patients was normal. In addition, as tumor stage or grade advanced, the positive rate of p16 aberrations also increased significantly (P<0.05). In conclusion, p16 gene aberrations may serve important roles in the auxiliary diagnosis of UC by FISH and could be utilized to monitor UC progression.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Yaxley JP: Urinary tract cancers: An overview for general practice. J Family Med Prim Care. 5:533–538. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Tyler A: Urothelial cancers: Ureter, renal pelvis, and bladder. Semin Oncol Nurs. 28:154–162. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Milojevic B, Dzamic Z, Kajmakovic B, Petronic Milenkovic D and Grujicic Sipetic S: Urothelial carcinoma: Recurrence and risk factors. J BUON. 20:391–398. 2015.PubMed/NCBI

6 

Ho CC, Tan WP, Pathmanathan R, Tan WK and Tan HM: Fluorescence-in-situ-hybridization in the surveillance of urothelial cancers: Can use of cystoscopy or ureteroscopy be deferred? Asian Pac J Cancer Prev. 14:4057–4059. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Mian C, Lodde M, Comploj E, Negri G, Egarter-Vigl E, Lusuardi L, Palermo S, Marberger M and Pycha A: Liquid-based cytology as a tool for the performance of uCyt+ and Urovysion Multicolour-FISH in the detection of urothelial carcinoma. Cytopathology. 14:338–342. 2003. View Article : Google Scholar : PubMed/NCBI

8 

Lin T, Liu Z, Liu L, Yang L, Han P, Zhang P and Wei Q: Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma. Oncol Lett. 13:3928–3934. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Reynolds JP, Voss JS, Kipp BR, Karnes RJ, Nassar A, Clayton AC, Henry MR, Sebo TJ, Zhang J and Halling KC: Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples. Cancer Cytopathol. 122:459–467. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 368:753–756. 1994. View Article : Google Scholar : PubMed/NCBI

11 

Qin SL, Chen XJ, Xu X, Shou JZ, Bi XG, Ji L, Han YL, Cai Y, Wei F, Ma JH, et al: Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization. Cancer Lett. 238:230–239. 2006. View Article : Google Scholar : PubMed/NCBI

12 

Gallucci M, Guadagni F, Marzano R, Leonardo C, Merola R, Sentinelli S, Ruggeri EM, Cantiani R, Sperduti I, Lopez Fde L and Cianciulli AM: Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: Correlation with adjacent mucosa and pathological parameters. J Clin Pathol. 58:367–371. 2005. View Article : Google Scholar : PubMed/NCBI

13 

Halling KC and Kipp BR: Bladder cancer detection using FISH (UroVysion assay). Adv Anat Pathol. 15:279–286. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Su X, Hao H, Li X, He Z, Gong K, Zhang C, Cai L, Zhang Q, Yao L, Ding Y, et al: Fluorescence in situ hybridization status of voided urine predicts invasive and high-grade upper tract urothelial carcinoma. Oncotarget. 8:26106–26111. 2017.PubMed/NCBI

15 

Bubendorf L: Multiprobe fluorescence in situ hybridization (UroVysion) for the detection of urothelial carcinoma-FISHing for the right catch. Acta Cytol. 55:113–119. 2011. View Article : Google Scholar : PubMed/NCBI

16 

Luo B, Li W, Deng CH, Zheng FF, Sun XZ, Wang DH and Dai YP: Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma. Cancer Genet Cytogenet. 189:93–97. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:436–440. 1994. View Article : Google Scholar : PubMed/NCBI

18 

Garg M: Epithelial plasticity in urothelial carcinoma: Current advancements and future challenges. World J Stem Cells. 8:260–267. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Amin MB: Histological variants of urothelial carcinoma: Diagnostic, therapeutic and prognostic implications. Mod Pathol. 22 Suppl 2:S96–S118. 2009. View Article : Google Scholar : PubMed/NCBI

20 

de Verdier Berggren PJ, Kumar R, Adolfsson J, Larsson P, Norming U, Onelöv E, Wijkström H, Steineck G and Hemminki K: Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancer. Scand J Urol Nephrol. 40:363–369. 2006. View Article : Google Scholar : PubMed/NCBI

21 

Ng SK, Casson RJ, Burdon KP and Craig JE: Chromosome 9p21 primary open-angle glaucoma susceptibility locus: A review. Clin Exp Ophthalmol. 42:25–32. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Simoneau M, LaRue HL, Aboulkassim TO, Meyer F, Moore L and Fradet Y: Chromosome 9 deletions and recurrence of supercial bladder cancer: Identication of four regions of prognostic interest. Oncogene. 19:6317–6323. 2000. View Article : Google Scholar : PubMed/NCBI

23 

Wang J, Wu J, Peng L, Tu P, Li W, Liu L, Cheng W, Wang X, Zhou S, Shi S, et al: Distinguishing urothelial carcinoma in the upper urinary tract from benign diseases with hematuria using FISH. Acta Cytol. 56:533–538. 2012. View Article : Google Scholar : PubMed/NCBI

24 

Sun JJ, Wu Y, Lu YM, Zhang HZ, Wang T, Yang XQ, Sun MH and Wang CF: Immunohistochemistry and fluorescence in situ hybridization can inform the differential diagnosis of low-grade noninvasive urothelial carcinoma with an inverted growth pattern and inverted urothelial papilloma. PLoS One. 10:e01335302015. View Article : Google Scholar : PubMed/NCBI

25 

Schwarz S, Rechenmacher M, Filbeck T, Knuechel R, Blaszyk H, Hartmann A and Brockhoff G: Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions. J Clin Pathol. 61:272–277. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Mao X, Li B, Liang Y, Li S, Zhou J, He Q, Jiang N, Chen Y, Sun Y, Cui Y, Cui Y, et al: Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma. Oncol Lett 15: 6533-6540, 2018.
APA
Mao, X., Li, B., Liang, Y., Li, S., Zhou, J., He, Q. ... Ke, Z. (2018). Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma. Oncology Letters, 15, 6533-6540. https://doi.org/10.3892/ol.2018.8137
MLA
Mao, X., Li, B., Liang, Y., Li, S., Zhou, J., He, Q., Jiang, N., Chen, Y., Sun, Y., Cui, Y., Jiang, W., Wang, H., Wang, L., Ke, Z."Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma". Oncology Letters 15.5 (2018): 6533-6540.
Chicago
Mao, X., Li, B., Liang, Y., Li, S., Zhou, J., He, Q., Jiang, N., Chen, Y., Sun, Y., Cui, Y., Jiang, W., Wang, H., Wang, L., Ke, Z."Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma". Oncology Letters 15, no. 5 (2018): 6533-6540. https://doi.org/10.3892/ol.2018.8137
Copy and paste a formatted citation
x
Spandidos Publications style
Mao X, Li B, Liang Y, Li S, Zhou J, He Q, Jiang N, Chen Y, Sun Y, Cui Y, Cui Y, et al: Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma. Oncol Lett 15: 6533-6540, 2018.
APA
Mao, X., Li, B., Liang, Y., Li, S., Zhou, J., He, Q. ... Ke, Z. (2018). Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma. Oncology Letters, 15, 6533-6540. https://doi.org/10.3892/ol.2018.8137
MLA
Mao, X., Li, B., Liang, Y., Li, S., Zhou, J., He, Q., Jiang, N., Chen, Y., Sun, Y., Cui, Y., Jiang, W., Wang, H., Wang, L., Ke, Z."Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma". Oncology Letters 15.5 (2018): 6533-6540.
Chicago
Mao, X., Li, B., Liang, Y., Li, S., Zhou, J., He, Q., Jiang, N., Chen, Y., Sun, Y., Cui, Y., Jiang, W., Wang, H., Wang, L., Ke, Z."Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma". Oncology Letters 15, no. 5 (2018): 6533-6540. https://doi.org/10.3892/ol.2018.8137
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team